Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial

Fluoroquinolones (FQs) have been reported to cause dysglycemia in both diabetic and non-diabetic patients. However, diabetic patients are usually on polypharmacy, so we cannot attribute the dysglycemia specifically to FQs. To answer the question as to whether Moxifloxacin and Gemifloxacin influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Abid, Ahmad, Shujaat, Ali, Niaz, Rahman, Shafiq Ur, Hussain, Haya, Alghamdi, Saad, Almehmadi, Mazen, Dablool, Anas S., Bannunah, Azzah M., Bukhari, Syeda Hajira, Almarshad, Feras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868483/
https://www.ncbi.nlm.nih.gov/pubmed/35203750
http://dx.doi.org/10.3390/antibiotics11020148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868483/
https://www.ncbi.nlm.nih.gov/pubmed/35203750
http://dx.doi.org/10.3390/antibiotics11020148

Ejemplares similares